Application of neoadjuvant chemotherapy and interval cytoreductive surgery in advanced epithelial ovarian cancer

Yuan Hang

doi:10.13406/j.cnki.cyxb.002818

您当前的位置：

首页 >

文章列表页 >

Application of neoadjuvant chemotherapy and interval cytoreductive surgery in advanced epithelial ovarian cancer

更新时间：2024-01-09

- Application of neoadjuvant chemotherapy and interval cytoreductive surgery in advanced epithelial ovarian cancer
- Journal of Chongqing Medical University Vol. 46, Issue 6, Pages: 644-648(2021)
- 作者机构：
  
  山东大学附属山东省妇幼保健院妇产科,济南,250014
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.002818
  CLC： R711
- Published：2021，
扫描看全文
Yuan Hang. Application of neoadjuvant chemotherapy and interval cytoreductive surgery in advanced epithelial ovarian cancer. [J]. Journal of Chongqing Medical University 46(6):644-648(2021)
DOI：

Yuan Hang. Application of neoadjuvant chemotherapy and interval cytoreductive surgery in advanced epithelial ovarian cancer. [J]. Journal of Chongqing Medical University 46(6):644-648(2021) DOI： 10.13406/j.cnki.cyxb.002818.

摘要

新辅助化疗及间歇性肿瘤细胞减灭术逐渐成为晚期上皮性卵巢癌治疗的主流模式之一，但其临床应用中仍有很多问题值得商榷。本文对新辅助化疗在晚期卵巢癌患者中的应用价值及争议等问题进行阐述，以期引起广大妇科肿瘤医师的重视和深入思考，并促进新辅助化疗的合理应用和临床研究。

Abstract

Neoadjuvant chemotherapy and interval cytoreductive surgery have gradually become one of the mainstream modes for treating advanced epithelial ovarian cancer

but there are still many problems in their clinical application which need to be considered. This article describes the value and controversies of the application of neoadjuvant chemotherapy in patients with advanced ovarian cancer

in order to arouse the attention and in-depth thinking of the majority of gynecological oncologists

and promote the rational application and clinical research of neoadjuvant chemotherapy.

关键词

上皮性卵巢癌新辅助化疗间歇性肿瘤细胞减灭术

Keywords

epithelial ovarian cancerneoadjuvant chemotherapyinterval cytoreductive surgery

references

Views

148

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pathomics signature based on machine learning can predict the response to neoadjuvant chemotherapy in breast cancer patients

DNA microarray screening for ovarian cancer associated fibroblasts

Study on radiotherapy plus neoadjuvant chemotherapy for patients with upper esophageal carcinoma

Prediction of chemosensitivity to combination neoadjuvant chemotherapy with carboplatin and 5-Fu for the patients with oral squamous cell carcinoma

Related Author

Yuan Hang

Zhang Shiqian

Yao Xiaopeng

Wang Jianmei

Wu Qi

Zhang Jieqiu

Linghu Hua

Ye Xiaolin

Related Institution

Department of Gynecology,Qilu Hospital of Shandong University

Department of Medical Engineering Technology，School of Medical Information and Engineering，Southwest Medical University

Department of Epidemiology and Health Statistics， School of Public Health，Southwest Medical University

Department of Pathology，The Affiliated Hospital of Southwest Medical University

Department of Obstetrics and Gynecology,The First Affiliated Hospital of Chongqing Medical University

⁰